Low-Dose Oral Minoxidil Initiation and Monitoring for Hair Loss: A Modified Delphi Consensus of Experts

The document discusses the development of consensus-based guidelines for the use of low-dose oral minoxidil (LDOM) in treating hair loss, involving 43 international hair loss specialists with significant experience. Through a multi-round modified Delphi process, consensus was achieved on 94 items related to LDOM's safety, efficacy, dosing, and monitoring. These items include diagnoses benefiting from LDOM, indications for its use over topical minoxidil, utilization in adults and adolescents, contraindications, precautions, dosing parameters, baseline evaluation, monitoring protocols, adjunctive therapy, and specialty consultation. The guidelines aim to provide best practices for LDOM use in hair loss treatment.